# Bristol-Myers Squibb Company (BMY) — Q1-2023 Earnings Results

**Report date:** 2023-04-27 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2023

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 0.6%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.05 | N/A | +3.33% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's future. They emphasized their focus on pipeline advancements despite current market challenges.

**Key quotes:**

> Management highlighted ongoing commitment to innovation and pipeline development.

> They acknowledged challenges in the market but expressed confidence in long-term growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report showed a positive surprise in EPS, which reflects better-than-expected performance in that area. However, the stock reacted negatively, declining by 0.6%. This may indicate investor concerns about other aspects of the business, particularly since no revenue figures or guidance were provided.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2023_